Kyle Wicks, PA
Physician Assistant · Roseburg, ORNPI 1750995577
Payments from drug & device makers
Across 194 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$405
- Novo Nordisk$220
- Amarin Pharma, Inc.$197
- AstraZeneca$196
- AbbVie$179
- Lilly USA, LLC$162
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,141100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 30 | $405 |
| Novo Nordisk | 11 | $220 |
| Amarin Pharma, Inc. | 16 | $197 |
| AstraZeneca | 11 | $196 |
| AbbVie | 13 | $179 |
| Lilly USA, LLC | 11 | $162 |
| Amgen | 8 | $161 |
| Boehringer Ingelheim | 7 | $159 |
| Daiichi Sankyo Inc. | 9 | $148 |
| Esperion Therapeutics, Inc. | 9 | $145 |
| GSK | 10 | $123 |
| Grifols USA, LLC | 7 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $109 |
| Pfizer | 5 | $107 |
| Mylan Specialty L.p. | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| E.r. Squibb & Sons, L.L.C. | 5 | $80 |
| Sanofi-aventis U.S. LLC | 4 | $77 |
| Biohaven Pharmaceuticals, Inc. | 4 | $72 |
| Merck | 4 | $60 |
| Novartis | 3 | $57 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Eisai Inc. | 1 | $22 |
| Bayer | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $12 |
How this compares
$3,141 in reported general payments places this provider in the 90th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 119 | $1,322 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 106 | $770 |
| Azithromycin | 152 | $648 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 49 | $583 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $582 |
| Doxycycline Monohydrate | 57 | $425 |
| ValacyclovirValacyclovir Hcl | 11 | $339 |
| Prednisone | 87 | $286 |
| Cephalexin | 48 | $261 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $141 |
| Triamcinolone Acetonide | 17 | $138 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 48 | $123 |
| Fluconazole | 18 | $119 |
| Ondansetron OdtOndansetron | 14 | $101 |
| Amoxicillin | 16 | $73 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Roseburg
- Devon ParksEugene$62K
- Ryan CainCorvallis$55K
- Sean BrownPortland$43K
- Pooja PatelWoodburn$41K
- Meegan MangumPortland$25K
- Scott FrazeePortland$24K
- Marissa ReenEugene$15K
- Debra Allen KutcherMedford$14K
- Hanna TynerBend$12K
- Amanda VansantEugene$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.